TRANSFORMING GROWTH-FACTOR-BETA IN NORMAL HUMAN LUNG - PREFERENTIAL LOCATION IN BRONCHIAL EPITHELIAL-CELLS

被引:76
作者
MAGNAN, A
FRACHON, I
RAIN, B
PEUCHMAUR, M
MONTI, G
LENOT, B
FATTAL, M
SIMONNEAU, G
GALANAUD, P
EMILIE, D
机构
[1] INSERM,U131,F-92140 CLAMART,FRANCE
[2] CTR CHIRURG MARIE LANNELONGUE,LE PLESSIS ROBINS,FRANCE
[3] HOP ANTOINE BECLERE,SERV ANAT PATHOL,CLAMART,FRANCE
[4] HOP ROBERT DEBRE,SERV ANAT PATHOL,F-75019 PARIS,FRANCE
[5] HOP ANTOINE BECLERE,SERV PNEUMOL,CLAMART,FRANCE
关键词
D O I
10.1136/thx.49.8.789
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background - Transforming growth factor beta (TGF-beta) is an immunomodulatory cytokine regulating the proliferation and differentiation of various cell types. It also contributes to the maintenance of tissue architecture by influencing the production of extracellular matrix components. TGF-beta has been detected in bronchoalveolar lavage fluid from normal human lung, but the nature and distribution of cells containing TGF-beta in this organ remain unknown. Methods - Fourteen normal human lung specimens were studied by immunohistochemistry with a monoclonal antibody recognizing TGF-beta(1), TGF-beta(2) and TGF-beta(3). Results - TGF-beta was detected in all cases. Bronchial epithelial cells contained the largest amounts of TGF-beta. In these cells the staining was brightest at the apical pole. Macrophages and smooth muscle cells also contained TGF-beta, although less than epithelial cells. No TGF-beta was detected in other cell populations, including endothelial cells, fibroblasts, and pneumocytes. Conclusions - The bronchial epithelial compartment appears to be the main location of TGF-beta in the normal human lung, suggesting that this cytokine has a pivotal role in the immunological properties of the bronchial mucosa.
引用
收藏
页码:789 / 792
页数:4
相关论文
共 31 条
  • [1] POLYMERASE CHAIN-REACTION AMPLIFICATION OF MESSAGES FOR GROWTH-FACTORS IN CELLS FROM HUMAN BRONCHOALVEOLAR LAVAGE FLUIDS
    ADOLFF, CH
    GOLDEN, JA
    KENNEDY, PW
    GOETZL, EJ
    TURCK, CW
    [J]. INFLAMMATION, 1991, 15 (04) : 259 - 268
  • [2] EXPRESSION AND SECRETION OF TYPE-BETA TRANSFORMING GROWTH-FACTOR BY ACTIVATED HUMAN MACROPHAGES
    ASSOIAN, RK
    FLEURDELYS, BE
    STEVENSON, HC
    MILLER, PJ
    MADTES, DK
    RAINES, EW
    ROSS, R
    SPORN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) : 6020 - 6024
  • [3] TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR
    BORDER, WA
    RUOSLAHTI, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) : 1 - 7
  • [4] TRANSFORMING GROWTH FACTOR-BETA-1 IS DECREASED IN REMODELING HYPERTENSIVE BOVINE PULMONARY-ARTERIES
    BOTNEY, MD
    PARKS, WC
    CROUCH, EC
    STENMARK, K
    MECHAM, RP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) : 1629 - 1635
  • [5] TRANSFORMING GROWTH FACTOR-BETA-1 IS PRESENT AT SITES OF EXTRACELLULAR-MATRIX GENE-EXPRESSION IN HUMAN PULMONARY FIBROSIS
    BROEKELMANN, TJ
    LIMPER, AH
    COLBY, TV
    MCDONALD, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) : 6642 - 6646
  • [6] DANIELE RP, 1990, ANNU REV PHYSIOL, V52, P177
  • [7] TRANSFORMING GROWTH-FACTOR-BETA IS A POTENT INHIBITOR OF INTERLEUKIN-1 (IL-1) RECEPTOR EXPRESSION - PROPOSED MECHANISM OF INHIBITION OF IL-1 ACTION
    DUBOIS, CM
    RUSCETTI, FW
    PALASZYNSKI, EW
    FALK, LA
    OPPENHEIM, JJ
    KELLER, JR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) : 737 - 744
  • [8] DIFFERENTIAL EFFECT OF TRANSFORMING GROWTH-FACTOR-BETA ON THE SYNTHESIS OF T(H)1-LYMPHOKINES AND T(H)2-LIKE LYMPHOKINES BY HUMAN LYMPHOCYTES-T
    FARGEAS, C
    WU, CY
    NAKAJIMA, T
    COX, D
    NUTMAN, T
    DELESPESSE, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) : 2173 - 2176
  • [9] VASCULAR SMOOTH-MUSCLE CELL HYPERTROPHY VS HYPERPLASIA - AUTOCRINE TRANSFORMING GROWTH FACTOR-BETA-1 EXPRESSION DETERMINES GROWTH-RESPONSE TO ANGIOTENSIN-II
    GIBBONS, GH
    PRATT, RE
    DZAU, VJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) : 456 - 461
  • [10] KEHRL JH, 1986, J IMMUNOL, V137, P3855